Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma.
| Image |  |
|---|---|
| Description | scientific article published on 29 April 2015 |
| Author/s |
author: Michelle Haber Selina Sutton Sela T Po'uha Jessica Koach Louis Chesler Owen Tan Belamy B Cheung Maria Kavallaris |
| Publication date | April 29, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |